Thymalin Dosage, half-life & reference guide

Also known as Timalin · Thymaline · Thymus peptide complex

Reviewed 1 studyEvidence: EmergingPublished by PepVault

A peptide extract of calf thymus from the Russian bioregulator program behind Epitalon, used as an immune drug. Its active parts include the dipeptides Vilon and Thymogen. In lab studies of human cells it moved blood stem cells toward mature T cells and lowered inflammatory signals; in people, its developers report fewer deaths among older adults followed for years and lower mortality in severe COVID-19, in studies not described as randomized.

How often
Daily
Half-life
Unknown
Evidence
●●● Emerging
Routes
IM, SubQ

No study indexed on PubMed states or tests a dose of Thymalin: the amounts people run are their own protocol, not a reference.

How it works.

A peptide extract of calf thymus, one of the first two products of Vladimir Khavinson's St. Petersburg bioregulator program, used as an immune drug. Its active parts include two dipeptides the same group later made on their own: Lys-Glu (Vilon) and Glu-Trp (Thymogen). In human blood stem cells in the lab it pushed immature cells toward mature T cells, and in human immune cells it and its two dipeptides lowered the inflammatory signals IL-1β, IL-6 and TNF-α. In people, a study of 266 older adults followed for 6 to 8 years reported fewer deaths with it than in a control group, and in severe COVID-19 its developers report lower hospital mortality when it was added to basic therapy; neither study is described as randomized or blinded, and almost all of the work is by its developers. It is a different substance from thymulin and from thymosin alpha-1.

Commonly reported: Little to feel during a course; injection-site soreness is the usual complaint.

A smiling man in a grey training top on a sofa with a foam roller beside him, his phone in his hands

PepVault for iPhone

Track thymalin in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Where Thymalin works.

A body with Immune system and Energy & longevity lit
  • Immune system

    In people. The Russian studies read Thymalin in blood work: more lymphocytes, fewer clotting markers, calmer inflammatory signals.

  • Energy & longevity

    In people. In people, a study of 266 older adults followed for 6 to 8 years reported fewer deaths with it than in a control group.

An area lights for what a peptide is used for and what people report, with the evidence beside it. It isn’t a promise that it works there.

Week by week.

What to expect in the first 8 weeks

Onset
Not established (no controlled timing data)
Peak effect
Not established
Duration
Courses of 5–10 days (community practice)
  1. Day 1–10Community

    A short course, then a long gap

    Thymalin is given in courses of about a week to ten days, then not for months. Commonly reported: little to feel during the course; soreness where it goes in is the usual complaint.

    Updated Nov 2026

  2. Day 10–60Clinical

    What the studies measured after a course

    The Russian studies read Thymalin in blood work: more lymphocytes, fewer clotting markers, calmer inflammatory signals. If you have blood work planned, a count after a course is the closest you can get to what they measured.

    The science

    In severe COVID-19, middle-aged and older patients given Thymalin with basic therapy had about twice the lymphocytes and monocytes and lower fibrinogen, LDH and D-dimer than those on basic therapy alone (Kuznik 2022). Its developers report faster falls in IL-6, C-reactive protein and D-dimer when it was added to standard care (Khavinson 2021).

    Sources
    • Kuznik et al. (2022)
    • Khavinson et al. (2021)

    Updated Nov 2026

  3. Any dayClinical

    What Thymalin is built on

    A calf-thymus extract from the Russian bioregulator program, used as an immune drug. In lab studies of human cells it pushed stem cells toward mature T cells and calmed inflammatory signals; its human studies are its developers', not randomized as far as their abstracts say.

    The science

    Lab: in human hematopoietic stem cells it lowered CD44 and CD117 two to three times and raised CD28 (Khavinson 2020); in human blood mononuclear cells stimulated with LPS, it and its dipeptides KE and EW cut IL-1β, IL-6 and TNF-α 1.4–6 times (Linkova 2023). The KE and EW dipeptides were found in it (Anisimov 2000; Linkova 2023). People: Khavinson 2003 (266 older adults, mortality); severe COVID-19 comparisons (Khavinson 2021; Kuznik 2022).

    Sources
    • Khavinson et al. (2020)
    • Linkova et al. (2023)
    • Anisimov et al. (2000)
    • Khavinson et al. (2003)
    • Khavinson et al. (2021)
    • Kuznik et al. (2022)

    Updated Nov 2026

  4. With EpitalonCommunity

    Paired with the pineal peptide, as in the long study

    Thymalin and the pineal extract Epithalamin were given together in the long Russian study of older adults, where the pair reported the largest drop in deaths. Epitalon is the synthetic peptide modelled on that extract, and no study has tested it with Thymalin.

    The science

    Khavinson and Morozov 2003: mortality 2.5 times lower with Thymalin plus Epithalamin than in the control group, and 4.1 times lower in a group given both every year for 6 years. Epitalon (Ala-Glu-Asp-Gly) was designed from Epithalamin's amino acids (Khavinson 2002).

    Sources
    • Khavinson et al. (2003)
    • Khavinson (2002)

    Updated Nov 2026

After week 8

  1. Day 60–365Clinical

    The long study in older adults

    Thymalin's best-known result is a study of 266 older adults followed for 6 to 8 years, which reported fewer deaths with Thymalin than in a control group. It was run by its developers and has not been repeated by another group.

    The science

    Khavinson and Morozov 2003: 266 elderly people followed 6–8 years, the peptides given in the first 2–3 years; deaths 2.0–2.1 times fewer with Thymalin, 1.6–1.8 with Epithalamin and 2.5 with both, against a control group, with fewer acute respiratory infections. How people were assigned to groups, and any blinding, are not described.

    Sources
    • Khavinson et al. (2003)

    Updated Nov 2026

Day 1 is the day you start it.

No placebo-controlled trial of Thymalin is indexed on PubMed. The human data are its developers' controlled comparisons, not described as randomized or blinded; the mechanism comes from lab studies of human cells.

Preliminary research

A typical run.

Run notes

Cycle
Run in short courses rather than continuously, like the other bioregulators: commonly 5–10 days, repeated months later. In the long Russian follow-up study, courses were given during the first two to three years only. No study has tested a course length.Community practice — opinions vary. Not a clinical recommendation.
Timing
No timing has been studied. As a drug it is injected into a muscle once a day during a course.
Routes
IM injection, SubQ injection
Stacks
Epitalon

Track it in the app

Safety.

Common side effects

  • Injection-site pain or redness
  • Firmness at the injection site

Interactions

No interaction studies exist. It is used to stimulate immunity, so medicines that suppress the immune system, and other immune peptides such as thymosin alpha-1, are worth raising with your clinician.

Safety notes

No modern safety study exists, and nothing is known about long-term use outside its developers' reports. It is an animal-tissue extract, a mixture rather than one molecule, so what a given vial holds depends on how it was made. Discuss with your clinician before use, particularly during pregnancy or breastfeeding, with an autoimmune condition, or alongside medicines that act on the immune system.

Goes with.

Questions people ask.

What is Thymalin?

A peptide extract of calf thymus from the Russian bioregulator program behind Epitalon, used as an immune drug. Its active parts include the dipeptides Vilon and Thymogen. In lab studies of human cells it moved blood stem cells toward mature T cells and lowered inflammatory signals; in people, its developers report fewer deaths among older adults followed for years and lower mortality in severe COVID-19, in studies not described as randomized.

How is Thymalin dosed in research?

The library carries no reference dose for Thymalin. No study indexed on PubMed states or tests a dose of Thymalin: the amounts people run are their own protocol, not a reference.

How long does Thymalin last?

The half-life of Thymalin is unknown (never measured).

What do people report on Thymalin?

Commonly reported on Thymalin: little to feel during a course; injection-site soreness is the usual complaint.

Is Thymalin safe?

The research basis for Thymalin is emerging: primarily preclinical / limited human data. Common side effects in the library: injection-site pain or redness and firmness at the injection site.

What does Thymalin stack with?

Common stacks for Thymalin: Epitalon.

Track it in the app

Research.

The literature

Search the latest research

Reference.

Cadence

Daily

Half-life

Unknown

Unknown (never measured)

Research basis

●●● Emerging

Primarily preclinical / limited human data

PepVault for iPhone

Track thymalin in PepVault

Log each dose, see how many doses are left in the vial, and keep your step-ups in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo

Reviewed How we check the library